Inova Labs, Inc.

DUBLIN, Aug. 3, 2023 /PRNewswire/ -- The "Global Long Term COVID Treatment: Market Shares, Strategies and Forecasts, 2023 to 2029" report from Wintergreen Research, Inc has been added to ResearchAndMarkets.com's offering. NIH in the US has funded researchers to study long term COVID causes and treatments. The Researching COVID to Enhance Recovery (RECOVER) initiative, has funded $1.15 billion. Treatment regimens for a range of long-lasting symptoms, including extreme fatigue, brain fog and shortness of breath are sought. NIH has focused on exercise, but more data is needed. A fundamental benefit of exercise is that it generates oxygen for the organs and muscles. Football players use supplemental oxygen to recover more quickly from a strenuous sprint during a game. So also, athletes use supplemental oxygen to gain an athletic advantage. The study is designed to give a comprehensive view of the Long Term COVID and Exercise Intolerance market. The research represents a selection from the mountains of data available of the most relevant and cogent market materials, with selections made by the most senior analysts. Commentary on every aspect of the market from independent analysts creates an independent perspective in the evaluation of the market. In this manner the study presents a comprehensive overview of what is going on in this market, assisting managers with designing market strategies likely to succeed. Key Factors Driving This Market: Exercise in the right amount and for the right duration can help cure long term COVID . Long Term COVID funding by NIH and others worldwide indicate vastly growing markets for supplemental oxygen and exercise clubs. In addition, oxygen companies are finding that providing the body with more oxygen before and after exercise allows users to achieve more energy and faster recuperation. For runners and endurance athletes, inhalable oxygen can be used to maximize oxygen intake, avoid muscle cramps and possibly reduce the risk of injury. When you inhale oxygen, it's absorbed into your blood, where hemoglobin proteins in red blood cells carry it to your muscles and tissues. Increasing oxygen availability can improve this whole process. Key Topics Covered: 1. Exercise Intolerance: Portable Oxygen Concentrator Market Description and Market Dynamics 1.1 Diagnosing and Treating People with Fatigue, People Who Are Challenged by Exercise 1.2 Pulmonary Arterial Hypertension (PAH), High Blood Pressure in the Lungs, Characterized by Exercise Intolerance 1.3 Oxygen Concentrator Uses 1.4 Oxygen Concentrator Insurance Coverage 1.5 Portable Oxygen Concentrator for Exercise Intolerance 2 Oxygen Long Term Treatment Market Driving Forces 2.1 Oxygen Long Term Treatment 2.2 Exercise Intolerance Cardio-Pulmonary Portable Oxygen Concentrator Market Shares 2.3 Portable Oxygen Concentrator Forecasts 2.4 Research White Paper: Supplemental Oxygen 2.5 Stationary Oxygen Concentrators 2.6 High Flow Oxygen Concentrators 2.7 Hyperbaric Oxygen HBOT 2.8 Exercise Intolerance Equipment Market Forecasts 2.9 Exercise Club Market Shares 2.10 Exercise Club Market Forecasts 2.11 Worldwide People Using Exercise Clubs Market Forecasts, Worldwide, 2023-2029 2.12 Worldwide People in Sports Clubs Market Forecasts, Worldwide, 2023-2029 2.13 Worldwide Patients on Oxygen Market Forecasts, Worldwide, 2023-2029 2.14 Portable Oxygen Concentrator Products 2.15 Portable Oxygen Concentrator Regional Market Analysis 3. Exercise Intolerance Portable Oxygen Concentrator for Heart Failure Market Dynamics 3.1 Chronic Fatigue and Long Term Covid 3.2 Portable Oxygen Concentrator 3.3 Chronic Fatigue Syndrome Recognized as a Disability Qualifying for Reimbursement 4. Types of Oxygen Systems 4.1 Oxygen Concentrator Applicable Population 4.2 Types of Oxygen Systems 4.3 Oxygen Concentrator Air Management 4.4 Pressure Swing Adsorption Principles 5 Portable Oxygen Equipment and Fitness Club Company Descriptions 24 Hour Fitness AirSep Anytime Fitness Applied Home Healthcare Equipment Besco Boost Oxygen Caire Medical Chart Industries ClubCorp Drive-DeVilbiss Healthcare Equinox First Class Medical Foshan Keyhub Electronic Industries Co., Ltd. Gardner Denver GSE Inogen Inova Labs Invacare Jiuxin Medical LA Fitness (Fitness International LLC) Leistung Engineering Lifetime Longfian Scitech Merits Nidek Medical NTK O2 Concepts Oxygo Philips Healthcare Precision Medical ResMed Sequal Teijin Group Thomas Compressors Virgin Active Zadro Health Solutions For more information about this report visit About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Media Contact: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Logo: SOURCE Research and Markets

13 Leading Anatomic Pathology Laboratories to Participate in AISight™ Early Access Program BOSTON, March 9, 2023 /PRNewswire/ -- PathAI, a global leader in AI-powered pathology, today announced the launch of AISight™, PathAI's digital pathology platform, and the AIM-PD-L1 NSCLC RUO algorithm1, which quantitates the percent of PD-L1 positive tumor and immune cells in non-small cell lung cancer (NSCLC) samples across the whole slide image (WSI), in 13 leading academic medical centers, health systems, reference laboratories, and independent pathology organizations across the United States. These organizations are part of PathAI's Early Access Program to gather real-world evidence about the use of digital pathology tools to advance precision medicine for the benefit of patients around the world. "We're pleased to bring our technology and the advantages of a digital pathology workflow directly to some of the country's leading laboratories," said Andrew Beck, MD, PhD, co-founder and CEO of PathAI. "This network of laboratories will serve as pioneers in transforming anatomic pathology and will be the first to access PathAI's extensive and growing menu of algorithm products across oncology and non-oncology indications." AISight is a digital pathology platform that was designed with input from more than 200 pathologists and can be used by physicians, academic institutions, biopharma companies, and CROs to support AI-driven research. The AIM-PD-L1 NSCLC RUO algorithm was built using a series of convolutional neural networks, each trained on a diverse real-world dataset consisting of more than 5,000 samples with inputs from 350,000+ cell and tissue-level annotations from 50+ pathologists. The algorithm analyzes NSCLC surgical specimens stained with any of the four major clones and provides quantification and visualizations of PD-L1 positivity on tumor and immune cells for use in immune oncology research applications. "We recognize the benefits that digital pathology will provide to pathologists, oncologists and other clinicians, but there are still barriers to its adoption that need to be overcome such as cost and confidence in algorithm performance," said Douglas Hartman, MD, Vice Chair of Pathology Informatics at The University of Pittsburgh Medical Center (UPMC), a world-renowned health system headquartered in Pittsburgh, Pennsylvania that operates 40 hospitals and more than 700 doctors' offices and outpatient centers. "PathAI has a deep understanding of these obstacles, as shown by their significant investment in creating a simple and intuitive user interface to easily interpret the outputs of their algorithms. We're pleased to be part of this first cohort of leading institutions to help advance the understanding and use of this technology." PathAI previously published validation data for the AIM-PD-L1 NSCLC Algorithm that was presented at the 2022 AACR Annual Meeting. As part of the AISight Early Access Network, participating laboratories will be building on this work to test the performance of the AIM-PD-L1 NSCLC algorithm on real-world data. These labs will also be able to access a suite of additional immunohistochemistry (IHC) quantitation algorithms across Breast Cancer, Urothelial Carcinoma, Head and Neck Squamous Cancer, and Melanoma. PathAI has previously published data in Modern Pathology highlighting the potential for AI-powered PD-L1 algorithms to identify more patients who would benefit from treatment with immuno-oncology therapy compared with current guidelines using manual assessment. "As a leader in precision medicine and digital pathology, PathGroup is committed to transforming patient care and providing our clients with cutting-edge technology," stated Derek Welch, MD, FCAP, Chief Medical Officer of Anatomic Pathology at PathGroup, one of the largest independent anatomic pathology laboratories in the United States serving more than 200 hospitals and 15,000 referring physicians. "Our partnership with PathAI allows us to deploy their AI-powered algorithms in our work to enhance our industry-leading efficiency and accuracy and improve outcomes for the patients who are at focus of everything we do." Participating institutions include: Reference Laboratories Caris Life Sciences (National) NeoGenomics Laboratories (National) TriCore Inc. (New Mexico) Independent Pathology Laboratories Celligent Diagnostics (North and South Carolina) PathAI Diagnostics (National) PathGroup (National) Academic Medical Centers & Health Systems Baylor Scott & White Health (Texas) Cleveland Clinic (Ohio) Inova Health (Virginia) Medstar Health (District of Columbia) Penn State Health (Pennsylvania) SUNY Upstate Medical University (New York) University of Pittsburgh Medical Center (Pennsylvania) To learn more about PathAI, AISight, and the AIM-PD-L1 NSCLC Algorithm, stop by Booth #639 at USCAP or register for an upcoming webinar on March 22nd, 2023. For more information regarding the AISight Early Access Network, please contact [email protected]. About PathAI PathAI is a leading provider of AI-powered research tools and services for pathology. PathAI's platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine and deep learning. Based in Boston, PathAI works with leading life sciences companies, laboratories, and researchers to advance precision medicine. To learn more, visit pathai.com. SOURCE PathAI

DUBLIN--( BUSINESS WIRE )--The "Medical Equipment Reports Subscription: Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028" report from Wintergreen Research, Inc has been added to ResearchAndMarkets.com's offering. The subscription includes access to 7 reports on the medical equipment industry, with access to report updates for one year. Choose any 7 studies for the Subscription: Home Oxygen Medical Equipment Medical Oxygen Concentrator Equipment, Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Hyperbaric Oxygen Therapy Equipment Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Stationary Oxygen Equipment Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Portable Oxygen Equipment Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 High Flow Oxygen Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Monitoring Devices Blood Pressure Monitors Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 EKG Monitors Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Pulse Oximeter - Oxygen Monitors - Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Blood Glucose Monitors Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Patient Monitors Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Fitness Device Monitors Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Vital Signs Monitors Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Diabetes Monitor Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Patient Monitor Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Pulse Oximeter Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Blood Plasma Blood Plasma Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Transportation Medical Equipment Wheelchair Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Air Medical Transport, Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Hospital Beds, Medical Furniture, and Patient Transport Units, Market Shares, Market Strategies, and Market Forecasts,2022 to 2028 Medical Testing, and Treatment Devices Air Medical Transport, Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Hospital Beds, Medical Furniture, and Patient Transport Units, Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 COVID Testing Products Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 iCPET Invasive Cardio Pulmonary Testing for Long Term Covid and Chronic Fatigue Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 PAH Invasive Cardio Pulmonary Treatments for Long Term Covid and Chronic Fatigue Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Oxygen Treatment for Cardio Pulmonary Vascular Impairment, Long Term Covid and Chronic Fatigue Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Chronic Heart Disease Not Caused by Blockages, 70% of Heart Disease, Cardio Pulmonary Testing for Long Term Covid and Chronic Fatigue Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Surgical Medical Robots Surgical Robots Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Orthopedic Surgical Robots Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Radiological Surgical Robots Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Abdominal Surgical Robots Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Cardiac Surgical Robots Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Robotics for radiotherapy Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Pharmaceutical Robots Pharmaceutical Robots Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Laboratory Robots Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Rehabilitation and Cleaning Robots Robotic prosthetics Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Rehabilitation robots Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Hospital Care Support Robots Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Cleaning Robots Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028 Medical equipment markets provide stable, steady, reliable sources of revenue generation. Hospital, long term care facilities, and clinical offices represent target markets. Monitoring, diagnosing, moving, tracking information, and treating people are done with medical equipment. A new generation of medical devices supports clinical tracking of chronic disease. World health organizations are supporting clinical caregivers that are leveraging monitoring and treatment delivery devices to improve the quality of care. Companies Mentioned 3B Medical, Inc. Ada Health GmbH, ADAC Service GmbH AGFA Gevaert Group Air Medical Group Holdings Air Methods AirSep Allscripts Healthcare, LLC Apex Medical athenahealth, Inc. Besco Beyond Medical BMC Medical Co., Ltd. Caire Medical Carestream Health CAS Medical Systems Cerner Corporation Chart Industries Covidien (Medtronic) CPAP Drager DRF Drive DeVilbiss HealthcareKoike Medical Drive-DeVilbiss Healthcare e-MDs Incorporation eClinicalWorks Epic Systems Corporation Fisher and Paykel Foshan Keyhub Electronic Industries Co., Ltd. Fosun Pharma Gardner Denver GE Healthcare Greenway Health, LLC. GSE Hewlett Packard Inogen Inova Labs Invacare Jiuxin Medical Leistung Engineering Longfian Scitech McKesson Corporation Medidata Solutions Inc. Merits Metro Aviation Mindray NextGen Healthcare Nidek Medical Nihon Kohden Novarad Corporation NTK NXGN Management, LLC, O2 Concepts Oracle OSI (Spacelabs) Oxygo PHI Philips Healthcare Philips Respironics Precision Medical Rega ResMed REVA Air Ambulance Royal Flying Doctor Service Schiller Sequal Siemens Healthineers Siilo SWORD Health Teijin Pharma Limited Zadro Health Solutions For more information about this report visit https://www.researchandmarkets.com/r/kw0skf-equipment?w=4